Compass Therapeutics (CMPX) Cash from Investing Activities (2019 - 2026)
Compass Therapeutics recorded quarterly Cash from Investing Activities of $38.4 million in Q1 2026, up 1237.63% quarter-over-quarter from -$3.4 million in Q4 2025, and up 231.63% year-over-year from $11.6 million in Q1 2025.
Compass Therapeutics' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $38.4 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 231.63% year-over-year to $38.4 million; the TTM figure through Mar 2026 stood at -$66.5 million (down 206.41% YoY), while the FY2025 annual figure was -$93.3 million, down 299.49% from the prior year.
- Cash from Investing Activities came in at $38.4 million for Q1 2026 at Compass Therapeutics, up from -$3.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $38.4 million in Q1 2026 to a low of -$105.5 million in Q2 2022.
- A 5-year average of -$7.8 million and a median of $1.2 million in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities sank 17089.09% in 2022 and surged 2311.92% in 2023, its largest moves.
- Compass Therapeutics' Cash from Investing Activities stood at -$46.6 million in 2022, then jumped by 113.54% to $6.3 million in 2023, then soared by 143.43% to $15.4 million in 2024, then sank by 121.98% to -$3.4 million in 2025, then soared by 1237.63% to $38.4 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $38.4 million, -$3.4 million, and -$95.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | 38.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.43 Mn |
| Mar 31, 2026 | 38.43 Mn |
| Dec 31, 2025 | -3.38 Mn |
| Dec 31, 2025 | -3.38 Mn |
| Sep 30, 2025 | -95.16 Mn |
| Sep 30, 2025 | -95.16 Mn |
| Jun 30, 2025 | -6.36 Mn |
| Jun 30, 2025 | -6.36 Mn |
| Mar 31, 2025 | 11.59 Mn |
| Mar 31, 2025 | 11.59 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Sep 30, 2024 | 29.02 Mn |
| Sep 30, 2024 | 29.02 Mn |
| Jun 30, 2024 | 6.48 Mn |
| Jun 30, 2024 | 6.48 Mn |
| Mar 31, 2024 | -4.10 Mn |
| Mar 31, 2024 | -4.10 Mn |
| Dec 31, 2023 | 6.31 Mn |
| Dec 31, 2023 | 6.31 Mn |
| Sep 30, 2023 | 17.05 Mn |
| Sep 30, 2023 | 17.05 Mn |
| Jun 30, 2023 | -667,000.00 |
| Jun 30, 2023 | -667,000.00 |
| Mar 31, 2023 | 4.27 Mn |
| Mar 31, 2023 | 4.27 Mn |
| Dec 31, 2022 | -46.65 Mn |
| Dec 31, 2022 | -46.65 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | -105.54 Mn |
| Jun 30, 2022 | -105.54 Mn |
| Mar 31, 2022 | -193,000.00 |
| Mar 31, 2022 | -193,000.00 |
| Dec 31, 2021 | -776,000.00 |
| Dec 31, 2021 | -776,000.00 |
| Sep 30, 2021 | -367,000.00 |
| Sep 30, 2021 | -367,000.00 |
| Jun 20, 2021 | -614,000.00 |
| Jun 20, 2021 | -614,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Sep 30, 2020 | 32,000.00 |
| Sep 30, 2020 | 32,000.00 |
| Jun 30, 2020 | 39,000.00 |
| Jun 30, 2020 | 39,000.00 |
| Mar 31, 2020 | -12,000.00 |
| Mar 31, 2020 | -12,000.00 |
| Sep 30, 2019 | -281,000.00 |
| Sep 30, 2019 | -281,000.00 |
| Jun 30, 2019 | -254,000.00 |
| Jun 30, 2019 | -254,000.00 |